Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Andrew Brohl

Associate Member

H Lee Moffitt Cancer Center and Research Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (12)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Russell Palm

The Ohio State University Comprehensive Cancer Center

UNITED STATES

View details

Marina Bastawrous Jacob

University of South Florida

UNITED STATES

View details

Nikhil Khushalani

Assistant Center Director for Clinical Research Review and Partnerships; Senior Member and Vice-Chair, Department of Cutaneous Oncology

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

David Thomas

Director

State Library of New South Wales

AUSTRALIA

View details

Glenn Hanna

Dana-Farber Cancer Institute

UNITED STATES

View details

Eissa Jafari

Assistant Professor

jazan university

SAUDI ARABIA

View details

Ahmad Tarhini

Senior Member, Professor

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

Paul Nghiem

Professor

University of Washington

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrew Brohl

Research Interests

Explore related searches

Articles (12)

Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial

Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-Analysis

Intratumoral Immunotherapy—The Future of Treating Merkel Cell Carcinoma?

Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma

The Chromosome 19 microRNA Cluster Facilitates Cancer Stemness in Hepatocellular Carcinoma

Checkpoint inhibitor therapy in immunosuppressed patients with Merkel cell carcinoma: not all immunosuppression is created equal

First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study

Biomarker Analyses Investigating Disease Biology and Associations with Outcomes in the JAVELIN Merkel 200 Trial of Avelumab in Metastatic Merkel Cell Carcinoma

First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0

Heritable defects in telomere and mitotic function selectively predispose to sarcomas

Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma

Anti-PD-1 therapy in advanced sarcomas: is cutaneous primary site a stronger predictor of response than histologic subtype?

Collaborators (8)

Russell Palm

Marina Bastawrous Jacob

Nikhil Khushalani

David Thomas

Glenn Hanna

Eissa Jafari

Ahmad Tarhini

Paul Nghiem

Make your next move.